Cargando…

Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data

BACKGROUND: Commentaries on the adequacy of insurance coverage for prescription drugs available to Canadians have emphasized differences in the coverage provided by different provincial governments. Less is known about the actual financial burden of prescription drug spending and how this burden var...

Descripción completa

Detalles Bibliográficos
Autores principales: McLeod, Logan, Bereza, Basil G, Shim, Minsup, Grootendorst, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Medicine Publications, Inc. 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205811/
https://www.ncbi.nlm.nih.gov/pubmed/22046212
_version_ 1782215367590936576
author McLeod, Logan
Bereza, Basil G
Shim, Minsup
Grootendorst, Paul
author_facet McLeod, Logan
Bereza, Basil G
Shim, Minsup
Grootendorst, Paul
author_sort McLeod, Logan
collection PubMed
description BACKGROUND: Commentaries on the adequacy of insurance coverage for prescription drugs available to Canadians have emphasized differences in the coverage provided by different provincial governments. Less is known about the actual financial burden of prescription drug spending and how this burden varies by province of residence, affluence and source of primary drug coverage. METHODS: We used data from a nationally representative household expenditure survey to analyze the financial burden of prescription drugs. We focused on the drug budget share (defined as the share of the household budget spent on prescription drugs), considering how it varied by province, total household budget and likely primary source of drug insurance coverage (i.e., provincial government plan for senior citizens, social assistance plan or private coverage). We examined both “typical” households (at the median of the distribution of the drug budget share) and households with relatively large shares (in the top 5%). Finally, we estimated the percentage of households with catastrophic drug expenditures (defined as a drug budget share of 10% or more) and the average catastrophic drug expenditures. RESULTS: Senior, social assistance and general population households accounted for 21.1%, 8.9% and 69.9% of the sample of 14 430 respondents to the 2006 Survey of Household Spending, respectively. The median drug budget share in Canada was 1.1% for senior households (range 0.4% [Ontario] to 3.6% [Saskatchewan]) and 0.1% for both social assistance households and general population households, with little appreciable variation across provinces for these latter 2 categories. The 95th percentile drug budget share in Canada was 7.4% for senior households (range 3.5% [Ontario] to 12.7% [Saskatchewan]), 5.4% for social assistance households (range 2.3% [British Columbia] to 13.0% [Prince Edward Island]) and 2.6% for general population households (range 2.1% [Ontario] to 5.4% [Prince Edward Island]). The interprovincial range of the 95th percentile drug budget share was 10.7 percentage points for social assistance households, 9.2 percentage points for senior households and 3.3 percentage points for general population households. INTERPRETATION: For most households, the financial burden of prescription drug expenditures appeared to be relatively small, with little interprovincial variation. However, a small number of households incurred catastrophic drug costs. These households were concentrated in the groups that traditionally benefit from provincial government drug plans. It is likely that some households did not purchase needed prescription drugs because of the expense, so our estimates of the financial burden of catastrophic prescription drug expenditures therefore represent a lower bound.
format Online
Article
Text
id pubmed-3205811
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Open Medicine Publications, Inc.
record_format MEDLINE/PubMed
spelling pubmed-32058112011-11-01 Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data McLeod, Logan Bereza, Basil G Shim, Minsup Grootendorst, Paul Open Med Research BACKGROUND: Commentaries on the adequacy of insurance coverage for prescription drugs available to Canadians have emphasized differences in the coverage provided by different provincial governments. Less is known about the actual financial burden of prescription drug spending and how this burden varies by province of residence, affluence and source of primary drug coverage. METHODS: We used data from a nationally representative household expenditure survey to analyze the financial burden of prescription drugs. We focused on the drug budget share (defined as the share of the household budget spent on prescription drugs), considering how it varied by province, total household budget and likely primary source of drug insurance coverage (i.e., provincial government plan for senior citizens, social assistance plan or private coverage). We examined both “typical” households (at the median of the distribution of the drug budget share) and households with relatively large shares (in the top 5%). Finally, we estimated the percentage of households with catastrophic drug expenditures (defined as a drug budget share of 10% or more) and the average catastrophic drug expenditures. RESULTS: Senior, social assistance and general population households accounted for 21.1%, 8.9% and 69.9% of the sample of 14 430 respondents to the 2006 Survey of Household Spending, respectively. The median drug budget share in Canada was 1.1% for senior households (range 0.4% [Ontario] to 3.6% [Saskatchewan]) and 0.1% for both social assistance households and general population households, with little appreciable variation across provinces for these latter 2 categories. The 95th percentile drug budget share in Canada was 7.4% for senior households (range 3.5% [Ontario] to 12.7% [Saskatchewan]), 5.4% for social assistance households (range 2.3% [British Columbia] to 13.0% [Prince Edward Island]) and 2.6% for general population households (range 2.1% [Ontario] to 5.4% [Prince Edward Island]). The interprovincial range of the 95th percentile drug budget share was 10.7 percentage points for social assistance households, 9.2 percentage points for senior households and 3.3 percentage points for general population households. INTERPRETATION: For most households, the financial burden of prescription drug expenditures appeared to be relatively small, with little interprovincial variation. However, a small number of households incurred catastrophic drug costs. These households were concentrated in the groups that traditionally benefit from provincial government drug plans. It is likely that some households did not purchase needed prescription drugs because of the expense, so our estimates of the financial burden of catastrophic prescription drug expenditures therefore represent a lower bound. Open Medicine Publications, Inc. 2011-01-04 /pmc/articles/PMC3205811/ /pubmed/22046212 Text en http://creativecommons.org/licenses/by-nc-sa/2.5/ca/ Open Medicine applies the Creative Commons Attribution Share Alike License, which means that anyone is able to freely copy, download, reprint, reuse, distribute, display or perform this work and that authors retain copyright of their work. Any derivative use of this work must be distributed only under a license identical to this one and must be attributed to the authors. Any of these conditions can be waived with permission from the copyright holder. These conditions do not negate or supersede Fair Use laws in any country.
spellingShingle Research
McLeod, Logan
Bereza, Basil G
Shim, Minsup
Grootendorst, Paul
Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data
title Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data
title_full Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data
title_fullStr Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data
title_full_unstemmed Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data
title_short Financial burden of household out-of-pocket expenditures for prescription drugs: Cross-sectional analysis based on national survey data
title_sort financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey data
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205811/
https://www.ncbi.nlm.nih.gov/pubmed/22046212
work_keys_str_mv AT mcleodlogan financialburdenofhouseholdoutofpocketexpendituresforprescriptiondrugscrosssectionalanalysisbasedonnationalsurveydata
AT berezabasilg financialburdenofhouseholdoutofpocketexpendituresforprescriptiondrugscrosssectionalanalysisbasedonnationalsurveydata
AT shimminsup financialburdenofhouseholdoutofpocketexpendituresforprescriptiondrugscrosssectionalanalysisbasedonnationalsurveydata
AT grootendorstpaul financialburdenofhouseholdoutofpocketexpendituresforprescriptiondrugscrosssectionalanalysisbasedonnationalsurveydata